These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 10807682

  • 21. Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors.
    Flau K, Redmer A, Liedtke S, Kathmann M, Schlicker E.
    Br J Pharmacol; 2002 Dec; 137(8):1355-61. PubMed ID: 12466246
    [Abstract] [Full Text] [Related]

  • 22. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
    Chieng B, Connor M, Christie MJ.
    Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
    [Abstract] [Full Text] [Related]

  • 23. Nociceptin/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata. A microdialysis study in the awake freely moving rat.
    Marti M, Guerrini R, Beani L, Bianchi C, Morari M.
    Neuroscience; 2002 Sep; 112(1):153-60. PubMed ID: 12044480
    [Abstract] [Full Text] [Related]

  • 24. Glycinergic inputs to cardiac vagal neurons in the nucleus ambiguus are inhibited by nociceptin and mu-selective opioids.
    Venkatesan P, Baxi S, Evans C, Neff R, Wang X, Mendelowitz D.
    J Neurophysiol; 2003 Sep; 90(3):1581-8. PubMed ID: 12761284
    [Abstract] [Full Text] [Related]

  • 25. Nocistatin inhibits 5-hydroxytryptamine release in the mouse neocortex via presynaptic Gi/o protein linked pathways.
    Fantin M, Fischetti C, Trapella C, Morari M.
    Br J Pharmacol; 2007 Oct; 152(4):549-55. PubMed ID: 17618307
    [Abstract] [Full Text] [Related]

  • 26. The nociceptin receptor-mediated inhibition of the rat rostral ventrolateral medulla neurons in vitro.
    Chu X, Xu N, Li P, Wang JQ.
    Eur J Pharmacol; 1999 Jan 01; 364(1):49-53. PubMed ID: 9920184
    [Abstract] [Full Text] [Related]

  • 27. Nociceptin and the ORL-1 ligand [Phe1psi (CH2-NH)Gly2]nociceptin(1-13)NH2 exert anti-opioid effects in the Freund's adjuvant-induced arthritic rat model of chronic pain.
    Bertorelli R, Corradini L, Rafiq K, Tupper J, Calò G, Ongini E.
    Br J Pharmacol; 1999 Nov 01; 128(6):1252-8. PubMed ID: 10578139
    [Abstract] [Full Text] [Related]

  • 28. Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist.
    Calo' G, Guerrini R, Bigoni R, Rizzi A, Marzola G, Okawa H, Bianchi C, Lambert DG, Salvadori S, Regoli D.
    Br J Pharmacol; 2000 Mar 01; 129(6):1183-93. PubMed ID: 10725267
    [Abstract] [Full Text] [Related]

  • 29. Opioid activity profiles indicate similarities between the nociceptin/orphanin FQ and opioid receptors.
    Hawkinson JE, Acosta-Burruel M, Espitia SA.
    Eur J Pharmacol; 2000 Feb 18; 389(2-3):107-14. PubMed ID: 10688973
    [Abstract] [Full Text] [Related]

  • 30. [Nphe(1)]nociceptin-(1-13)NH(2) selectively antagonizes nociceptin effects in the rabbit isolated ileum.
    Pheng LH, Calo G, Guerrini R, Regoli D.
    Eur J Pharmacol; 2000 Jun 02; 397(2-3):383-8. PubMed ID: 10844138
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. ORL-1 receptor mediates the action of nociceptin on ascending myenteric reflex pathways in rats.
    Yüce B, Sibaev A, Haaken A, Saur D, Allescher HD, Göke B, Timmermans JP, Storr M.
    Gastroenterology; 2007 Aug 02; 133(2):574-86. PubMed ID: 17681177
    [Abstract] [Full Text] [Related]

  • 33. Interactions of dynorphin A-(1-13) and nociceptin with cardiac D2 binding sites: inhibition of ischemia-evoked release of noradrenaline from synaptosomal-mitochondrial fractions.
    Dumont M, Lemaire S.
    J Mol Cell Cardiol; 2000 Aug 02; 32(8):1567-74. PubMed ID: 10900181
    [Abstract] [Full Text] [Related]

  • 34. Role of nociceptin/orphanin FQ and the pseudopeptide [Phe1Psi(CH2NH)Gly2]-nociceptin(1-13)-NH2 and their interaction with classic opioids in the modulation of thermonociception in the land snail Helix aspersa.
    Miller-Pérez C, Sánchez-Islas E, Pellicer F, Rodríguez-Manzo G, Cruz SL, León-Olea M.
    Eur J Pharmacol; 2008 Feb 26; 581(1-2):77-85. PubMed ID: 18096155
    [Abstract] [Full Text] [Related]

  • 35. The ORL-1 (NOP1) receptor ligand nociceptin/orphanin FQ (N/OFQ) inhibits neurogenic dural vasodilatation in the rat.
    Bartsch T, Akerman S, Goadsby PJ.
    Neuropharmacology; 2002 Nov 26; 43(6):991-8. PubMed ID: 12423668
    [Abstract] [Full Text] [Related]

  • 36. The putative OP(4) antagonist, [Nphe(1)]nociceptin(1-13)NH(2), prevents the effects of nociceptin in neuropathic rats.
    Corradini L, Briscini L, Ongini E, Bertorelli R.
    Brain Res; 2001 Jun 29; 905(1-2):127-33. PubMed ID: 11423087
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Interaction between 5-HT uptake inhibition and activation of 5-HT autoreceptors by exogenous agonists in rat cerebral cortex slices and synaptosomes.
    Bonanno G, Raiteri M.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar 29; 335(3):219-25. PubMed ID: 3473290
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Opioid effects on spinal [3H]5-hydroxytryptamine release are not related to their antinociceptive action.
    Monroe PJ, Kradel BK, Smith DL, Smith DJ.
    Eur J Pharmacol; 1995 Jan 05; 272(1):51-6. PubMed ID: 7713149
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.